These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8829124

  • 1. Apolipoprotein E genotypes and risk of diabetic nephropathy.
    Onuma T, Laffel LM, Angelico MC, Krolewski AS.
    J Am Soc Nephrol; 1996 Jul; 7(7):1075-8. PubMed ID: 8829124
    [Abstract] [Full Text] [Related]

  • 2. LDL subclasses in IDDM patients: relation to diabetic nephropathy.
    Lahdenperä S, Groop PH, Tilly-Kiesi M, Kuusi T, Elliott TG, Viberti GC, Taskinen MR.
    Diabetologia; 1994 Jul; 37(7):681-8. PubMed ID: 7958539
    [Abstract] [Full Text] [Related]

  • 3. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK, Rhee SY, Chon S, Oh S, Woo JT, Kim SW, Kim JW, Kim YS, Jeong KH, Lee SH, Lee TW, Ihm CG.
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [Abstract] [Full Text] [Related]

  • 4. Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group.
    Hadjadj S, Gallois Y, Simard G, Bouhanick B, Passa P, Grimaldi A, Drouin P, Tichet J, Marre M.
    Nephrol Dial Transplant; 2000 Dec; 15(12):1971-6. PubMed ID: 11096142
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
    Atageldiyeva KK, Nemr R, Echtay A, Racoubian E, Sarray S, Almawi WY.
    Gene; 2019 Oct 05; 715():144011. PubMed ID: 31357022
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.
    Roussos L, Ekström U, Ehle PN, Oqvist B, Floren CH.
    Scand J Urol Nephrol; 2004 Oct 05; 38(6):504-10. PubMed ID: 15841787
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
    Werle E, Fiehn W, Hasslacher C.
    Diabetes Care; 1998 Jun 05; 21(6):994-8. PubMed ID: 9614620
    [Abstract] [Full Text] [Related]

  • 8. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.
    Chen JW, Hansen PM, Tarnow L, Hellgren A, Deckert T, Pociot F.
    Diabet Med; 1997 Feb 05; 14(2):143-7. PubMed ID: 9047092
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
    Hsieh MC, Lin SR, Yang YC, Chen HC, Lin JN, Shin SJ.
    J Nephrol; 2002 Feb 05; 15(4):368-73. PubMed ID: 12243365
    [Abstract] [Full Text] [Related]

  • 12. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients.
    Karimoei M, Pasalar P, Mehrabzadeh M, Daneshpour M, Shojaee M, Forouzanfar K, Razi F.
    Saudi J Kidney Dis Transpl; 2017 Feb 05; 28(5):997-1002. PubMed ID: 28937055
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.
    Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K.
    Am J Kidney Dis; 2002 Aug 05; 40(2):243-51. PubMed ID: 12148096
    [Abstract] [Full Text] [Related]

  • 15. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
    Araki S, Koya D, Makiishi T, Sugimoto T, Isono M, Kikkawa R, Kashiwagi A, Haneda M.
    Diabetes Care; 2003 Aug 05; 26(8):2416-20. PubMed ID: 12882872
    [Abstract] [Full Text] [Related]

  • 16. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
    Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS.
    Kidney Int; 2000 Feb 05; 57(2):405-13. PubMed ID: 10652017
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.
    Diabetes Care; 1996 Dec 05; 19(12):1382-7. PubMed ID: 8941468
    [Abstract] [Full Text] [Related]

  • 19. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
    Maeda S, Haneda M, Guo B, Koya D, Hayashi K, Sugimoto T, Isshiki K, Yasuda H, Kashiwagi A, Kikkawa R.
    Kidney Int; 2001 Oct 05; 60(4):1428-34. PubMed ID: 11576356
    [Abstract] [Full Text] [Related]

  • 20. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.
    Liu L, Xiang K, Zheng T, Zhang R, Li M, Li J.
    Mol Cell Biochem; 2003 Dec 05; 254(1-2):353-8. PubMed ID: 14674716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.